NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 309 filers reported holding NEOGENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $249,222 | -24.1% | 20,262 | -0.9% | 0.00% | -100.0% |
| Q2 2023 | $328,567 | -33.3% | 20,446 | -27.7% | 0.00% | 0.0% |
| Q1 2023 | $492,424 | +772.4% | 28,284 | +363.0% | 0.00% | – |
| Q4 2022 | $56,447 | +8.6% | 6,109 | +0.2% | 0.00% | – |
| Q3 2022 | $52,000 | +8.3% | 6,095 | +1.5% | 0.00% | – |
| Q2 2022 | $48,000 | -92.3% | 6,004 | -88.3% | 0.00% | -100.0% |
| Q1 2022 | $620,000 | -94.6% | 51,101 | -84.9% | 0.00% | -92.3% |
| Q4 2021 | $11,551,000 | – | 338,555 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |